Lipid Nanoparticles Market Share

Statistics for the 2023 & 2024 Lipid Nanoparticles market share, created by Mordor Intelligence™ Industry Reports. Lipid Nanoparticles share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Lipid Nanoparticles Industry

The lipid nanoparticles market is semi-consolidated in nature due to the presence of some key players operating globally as well as regionally. The competitive landscape includes an analysis of a few international and local companies that hold considerable market share and are well known. They include Merck KGaA, Croda International PLC, Cytiva, BIOVECTRA, Acuitas Therapeutics, CordenPharma, Genevant Sciences Corporation, Arcturus Therapeutics Inc., Ascendia Pharmaceuticals, and CD Bioparticles.

Lipid Nanoparticles Market Leaders

  1. Merck KGaA

  2. Arcturus Therapeutics, Inc.

  3. Ascendia Pharmaceuticals

  4. Acuitas Therapeutics

  5. Croda International Plc.

*Disclaimer: Major Players sorted in no particular order

Lipid Nanoparticles Market Concentration

Lipid Nanoparticles Market Size & Share Analysis - Growth, Trends, and Forecasts (2024 - 2029)